EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation

Giuseppe Biscaglia iD, Annamaria Gentile, Paola Parente iD, Annamaria Calvo, Rosanna Fontana, Antonio Continisio, Anna Laura Pia Di Brina, Davide Ciardiello, Gillian McIlwain, Anna Latiano, Francesco Perri iD, Orazio Palmieri iD

Nutrients · 2025

DOI: 10.3390/nu17233788 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Giuseppe Biscaglia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, Graft vs Host Disease, Inflammatory Bowel Diseases. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Italian Ministry of Health (Ricerca Corrente) and 5 per mille, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fecal microbiota transplantation (FMT) is a therapeutic strategy designed to modify and enrich the recipient’s gut microbiota by administering processed donor stool, with the goal of treating dysbiosis and related conditions. In 2013, the United States Food and Drug Administration (FDA) approved FMT for recurrent Clostridioides difficile infection (rCDI). Since then, its use has been proposed and investigated in several other disorders characterized by gut microbiota imbalance and altered host–microbiota interactions, including inflammatory bowel disease (IBD), immune checkpoint inhibitor-induced colitis (ICI-iC), and gastrointestinal graft-versus-host disease (GI-GVHD). This review aims to highlight the commonalities among these conditions, the pathophysiological mechanisms that support the rationale for FMT, and emerging evidence from clinical studies. Although available studies are heterogeneous, FMT is a rapidly evolving field of research with promising potential to treat IBD and improve outcomes following oncological immunotherapy and allogenic stem cell transplantation. With further validation, FMT could become an important approach in managing immune-mediated gastrointestinal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationImmune Checkpoint InhibitorsGraft vs Host DiseaseInflammatory Bowel DiseasesColitisHumansGastrointestinal Microbiome

Stichwörter der Autor:innen

CDFMTGVHDIBDICI-iCUC

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
  • Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
  • Microbiology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
  • Section of Gastroenterology, Department of Emergency and Organ Transplantation, University "Aldo Moro" Bari, 70121 Bari, Italy.
  • Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, 20141 Milan, Italy.
  • Medical School, The University of Queensland, Herston, QLD 4006, Australia.

ORCID-Profile: Giuseppe Biscaglia, Paola Parente, Francesco Perri, Orazio Palmieri

Förderung

  • This research was funded by the Italian Ministry of Health (Ricerca Corrente) and 5 per mille
  • Italian Ministry of Health

Zitieren

APA

Biscaglia, G., Gentile, A., Parente, P., Calvo, A., Fontana, R., Continisio, A., Di Brina, A. L. P., Ciardiello, D., McIlwain, G., Latiano, A., Perri, F., & Palmieri, O. (2025). Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation. Nutrients. https://doi.org/10.3390/nu17233788

Vancouver

Biscaglia G, Gentile A, Parente P, Calvo A, Fontana R, Continisio A, et al. Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation. Nutrients. 2025. doi:10.3390/nu17233788

BibTeX
@article{Biscaglia2025,
  author = {Biscaglia, Giuseppe and Gentile, Annamaria and Parente, Paola and Calvo, Annamaria and Fontana, Rosanna and Continisio, Antonio and Di Brina, Anna Laura Pia and Ciardiello, Davide and McIlwain, Gillian and Latiano, Anna and Perri, Francesco and Palmieri, Orazio},
  title = {Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17233788}
}
Kostenlos starten →